Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Sep 26, 2017 8:16pm

96 Views

Post# 26745513

RE:RE:RE:RE:RE:RE:RE:RE:TLD-1433 binding to local metastasis to prevent recurrences

Hi bencro; I agree that something has got to give. We all know that nothing happens with funding. It just hurts to think that a discounted PP could take place when Theralase has shown such magnificent progress without a fair uptick in our market value. In todays market, $60 millIon CAD is just stupid cheap. Than a discount too! The best of luck to you and all longs. made2last

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario